Genomic Profiling Reveals Aggressive Tumor Subtypes Driving Racial Survival Gaps

Got story updates? Submit your updates here. ›

A new study of over 1,000 women with breast cancer has found that genomic risk and molecular subtype, rather than race, are the primary factors behind differential survival outcomes. The research, which utilized MammaPrint and BluePrint genomic profiling tools, suggests that addressing these underlying biological factors could help reduce racial disparities in breast cancer mortality.

Why it matters

Racial disparities in breast cancer survival rates have long been a major public health concern, with Black women experiencing significantly higher mortality compared to white women. This study provides important insights into the root causes of these disparities, shifting the focus away from race and towards the genetic and molecular characteristics of tumors.

The details

The study analyzed data from over 1,000 women with breast cancer, examining how factors like genomic risk and molecular subtype impacted survival rates. Researchers found that aggressive tumor subtypes, rather than race, were the key drivers behind differential outcomes. By utilizing advanced genomic profiling tools like MammaPrint and BluePrint, the study was able to provide a more nuanced understanding of the biological factors underlying survival disparities.

• The study was conducted between 2020 and 2025.

What’s next

The researchers plan to further investigate how targeted therapies and interventions tailored to specific genomic profiles and molecular subtypes could help reduce racial disparities in breast cancer outcomes.